Moreover, Li et al. found a positive association between Nrf2 and VDR expression levels, and in their study, eriodictyol activated the Nrf2/HO-1 signaling pathway through the VDR to mitigate the pathological effects of Alzheimer’s disease [52]. Here, NFE2L2 is linked to early-onset autosomal dominant Alzheimer disease.